CAS 312693-72-4|2'-Deoxyguanosine monohydrate
| Common Name | 2'-Deoxyguanosine monohydrate | ||
|---|---|---|---|
| CAS Number | 312693-72-4 | Molecular Weight | 267.24100 |
| Density | / | Boiling Point | 801.4ºC at 760 mmHg |
| Molecular Formula | C10H13N5O4 | Melting Point | 300ºC |
| MSDS | ChineseUSA | Flash Point | 438.5ºC |
| Symbol | GHS07 | Signal Word | Warning |
Names
| Name | 2'-deoxyguanosine |
|---|
Chemical & Physical Properties
| Boiling Point | 801.4ºC at 760 mmHg |
|---|---|
| Melting Point | 300ºC |
| Molecular Formula | C10H13N5O4 |
| Molecular Weight | 267.24100 |
| Flash Point | 438.5ºC |
| Exact Mass | 267.09700 |
| PSA | 139.28000 |
| Storage condition | 2-8°C |
Safety Information
| Symbol | GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302 |
| Hazard Codes | Xi |
| RIDADR | NONH for all modes of transport |
| HS Code | 2934999090 |
Customs
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Articles6
More Articles| Induction of ROS generation by fluconazole in Candida glabrata: activation of antioxidant enzymes and oxidative DNA damage. Diagn. Microbiol. Infect. Dis. 82 , 203-8, (2015) In this study, we assessed the generation of reactive oxygen species (ROS) induced by subinhibitory concentration of fluconazole in susceptible and resistant Candida glabrata strains at stationary gro... | |
| Copper/H2O2-mediated oxidation of 2'-deoxyguanosine in the presence of 2-naphthol leads to the formation of two distinct isomeric adducts. J. Org. Chem. 76(19) , 7953-63, (2011) Exposure of cells to phenolic compounds through exogenous and endogenous sources can lead to deleterious effects via nucleobase modifications of DNA occurring under oxidative conditions. 2'-Deoxyguano... | |
| Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine as a biomarker in type 2 diabetes. Free Radic. Biol. Med. 51(8) , 1473-9, (2011) The increasing prevalence of diabetes together with the associated morbidity and mortality calls for additional preventive and therapeutic strategies. New biomarkers that can be used in therapy contro... |
